Muscle cells from mdx mice have an increased susceptibility to oxidative stress

[1]  R. Mason,et al.  The origin of the hydroxyl radical oxygen in the Fenton reaction. , 1997, Free radical biology & medicine.

[2]  J. Haycock,et al.  Oxidative damage to muscle protein in Duchenne muscular dystrophy , 1996, Neuroreport.

[3]  J. Stull,et al.  Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. D. Porter,et al.  Extraocular, limb and diaphragm muscle group-specific antioxidant enzyme activity patterns in control and mdx mice , 1996, Journal of the Neurological Sciences.

[5]  M. Jackson,et al.  How does dystrophin deficiency lead to muscle degeneration? — Evidence from the MDX mouse , 1995, Neuromuscular Disorders.

[6]  K. Widhalm,et al.  Oxyradical damage and mitochondrial enzyme activities in the mdx mouse. , 1995, Neuropediatrics.

[7]  R. H. Brown.  Free radicals, programmed cell death and muscular dystrophy. , 1995, Current opinion in neurology.

[8]  T. Kizaki,et al.  Alterations of superoxide dismutase iso-enzyme activity, content, and mRNA expression with aging in rat skeletal muscle , 1995, Mechanisms of Ageing and Development.

[9]  K. Aldape,et al.  Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy , 1995, Cell.

[10]  R. Abresch,et al.  Profiles of neuromuscular diseases. Becker's muscular dystrophy. , 1995, American journal of physical medicine & rehabilitation.

[11]  B. Halliwell,et al.  Nitric oxide and oxygen radicals: a question of balance , 1995, FEBS letters.

[12]  S. Lipton,et al.  Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Kizaki,et al.  Superoxide dismutase derivative reduces oxidative damage in skeletal muscle of rats during exhaustive exercise. , 1995, Journal of applied physiology.

[14]  J. Gillis,et al.  Site‐dependent pathological differences in smooth muscles and skeletal muscles of the adult MDX mouse , 1995, Muscle & nerve.

[15]  M. Raff,et al.  Programmed cell death and Bcl-2 protection in very low oxygen , 1995, Nature.

[16]  H. Blau,et al.  Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy , 1994, The Journal of cell biology.

[17]  G. Dudley,et al.  Influence of exercise and fiber type on antioxidant enzyme activity in rat skeletal muscle. , 1994, The American journal of physiology.

[18]  P. Cerutti,et al.  Glutathione peroxidase compensates for the hypersensitivity of Cu,Zn-superoxide dismutase overproducers to oxidant stress. , 1994, The Journal of biological chemistry.

[19]  G. Fantini,et al.  Deferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle. , 1993, The American journal of physiology.

[20]  D. Bredesen,et al.  bcl-2 inhibits death of central neural cells induced by multiple agents. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  H. Sweeney,et al.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  L. Austin,et al.  Potential oxyradical damage and energy status in individual muscle fibres from degenerating muscle diseases , 1992, Neuromuscular Disorders.

[23]  S. Orrenius,et al.  Calcium-mediated mechanisms in chemically induced cell death. , 1992, Annual review of pharmacology and toxicology.

[24]  B. Cooper,et al.  Canine X-linked muscular dystrophy: Selective involvement of muscles in neonatal dogs , 1991, Neuromuscular Disorders.

[25]  W. Denetclaw,et al.  Increased calcium influx in dystrophic muscle , 1991, The Journal of cell biology.

[26]  E. Ricci,et al.  Progressive depletion of fast alpha‐actinin‐positive muscle fibers in Duchenne muscular dystrophy , 1991, Neurology.

[27]  P. Cerutti,et al.  The balance between copper-zinc superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress , 1991 .

[28]  J. Shrager,et al.  The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy , 1991, Nature.

[29]  E. Hoffman,et al.  Chapter 8 The Animal Models of Duchenne Muscular Dystrophy: Windows on the Pathophysiological Consequences of Dystrophin Deficiency , 1991 .

[30]  J. Weinberg,et al.  Protection by glycine of proximal tubules from injury due to inhibitors of mitochondrial ATP production. , 1990, The American journal of physiology.

[31]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Dooley,et al.  Effects of 2,2'-azobis (2-amidinopropane) hydrochloride in vivo and protection by vitamin E. , 1990, Free radical biology & medicine.

[33]  E A Barnard,et al.  The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. , 1989, Science.

[34]  J P Kehrer,et al.  Oxidative stress and muscular dystrophy. , 1989, Chemico-biological interactions.

[35]  J. Miller,et al.  Clinical investigation in Duchenne muscular dystrophy: Penicillamine and vitamin E , 1988, Muscle & nerve.

[36]  V. Ionasescu,et al.  X‐linked dominant charcot–marie–tooth neuropathy with 15 cases in a family genetic linkage study , 1988, Muscle & nerve.

[37]  S. Carpenter,et al.  Small‐caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy , 1988, Muscle & nerve.

[38]  R. Lynch,et al.  Superoxide mediates the toxicity of paraquat for cultured mammalian cells. , 1988, The Journal of biological chemistry.

[39]  M. Lovett,et al.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Feelisch,et al.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. , 1987, European journal of pharmacology.

[41]  G. Fenichel,et al.  Superoxide dismutases, Glutathione peroxidase, And catalase in neuromuscular Disease , 1987, Muscle & nerve.

[42]  Y. Mizuno.  Changes in superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activities and thiobarbituric acid-reactive products levels in early stages of development in dystrophic chickens , 1984, Experimental Neurology.

[43]  S. Orrenius,et al.  The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. , 1982, The Journal of biological chemistry.

[44]  L. Rowland.  Biochemistry of muscle membranes in Duchenne muscular dystrophy , 1980, Muscle & nerve.

[45]  D. Buchanan,et al.  Treatment of Duchenne's muscular dystrophy with penicillamine. Results of a double-blind trial. , 1979, Archives of neurology.

[46]  C. Pearson,et al.  The Striated muscle , 1973 .

[47]  W. Engel,et al.  Duchenne Muscular Dystrophy: Functional Ischemia Reproduces Its Characteristic Lesions , 1971, Science.